{"schema_version":"secwatch.filing_event.v1","accession":"0001842952-22-000009","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2022-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.784539+00:00","generated_at":"2026-06-27T19:36:15.669018+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Context Therapeutics updates corporate presentation, no new figures disclosed","bullets":["Filed an updated corporate presentation dated January 2022 under Item 8.01.","Presentation titled 'Bringing Change for Female Cancers' but contains no disclosed financial or pipeline specifics.","No material operational or financial updates beyond the filing itself.","Ticker: CNTX; stock trades on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001842952-22-000009","json":"https://secwatch.observer/filing/0001842952-22-000009.json","markdown":"https://secwatch.observer/filing/0001842952-22-000009.md","text":"https://secwatch.observer/filing/0001842952-22-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000184295222000009/0001842952-22-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000184295222000009/cntx-20220110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T19:36:15.669018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}